Breast cancer tissue slices as a model for evaluation of response to rapamycin (Q38490536)

3 September 2017

title

Breast cancer tissue slices as a model for evaluation of response to rapamycin (English)

1 reference

3 September 2017

author

Helena Paula Brentani

6

object named as

Helena Brentani

1 reference

3 September 2017

author name string

Stana Helena Giorgi Grosso

1

1 reference

3 September 2017

Maria Lucia Hirata Katayama

2

1 reference

3 September 2017

Rosimeire Aparecida Roela

3

1 reference

3 September 2017

Suely Nonogaki

4

1 reference

3 September 2017

Fernando Augusto Soares

5

1 reference

3 September 2017

Leandro Lima

7

1 reference

3 September 2017

Maria Aparecida Azevedo Koike Folgueira

8

1 reference

3 September 2017

Angela Flávia Logullo Waitzberg

9

1 reference

3 September 2017

Fátima Solange Pasini

10

1 reference

3 September 2017

João Carlos Guedes Sampaio Góes

11

1 reference

3 September 2017

M Mitzi Brentani

12

1 reference

3 September 2017

publication date

1 May 2013

1 reference

3 September 2017

published in

Cell and Tissue Research

1 reference

3 September 2017

volume

352

1 reference

3 September 2017

issue

3

1 reference

3 September 2017

page(s)

671-684

1 reference

The rapamycin-regulated gene expression signature determines prognosis for breast cancer

3 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Network biology: understanding the cell's functional organization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Vitamin D3 modulation of plasminogen activator inhibitor type-1 in human breast carcinomas under organ culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

A novel tissue-slice culture model for non-malignant human prostate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Oncogene activation induces metabolic transformation resulting in insulin-independence in human breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

The Akt pathway in human breast cancer: a tissue-array-based analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Network-based classification of breast cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

FKBP12-rapamycin-associated protein associates with mitochondria and senses osmotic stress via mitochondrial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

The phosphatidyl inositol 3-kinase signaling network: implications for human breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Stromal gene expression predicts clinical outcome in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Defining the role of mTOR in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Deciphering downstream gene targets of PI3K/mTOR/p70S6K pathway in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Targeting the phosphatidylinositol 3-kinase signaling pathway in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

The mammalian target of rapamycin inhibitor everolimus (RAD001) in early breast cancer: results of a pre-operative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Targeting the mTOR signaling network for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Human breast tumor slices: a model for identification of vitamin D regulated genes in the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Estradiol modulation of plasminogen activator production in organ cultures of human breast carcinomas: correlation with clinical outcome of anti-estrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Determinants of rapamycin sensitivity in breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Biomarker Development for the Clinical Activity of the mTOR Inhibitor Everolimus (RAD001): Processes, Limitations, and Further Proposals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Regulation of macroautophagy by mTOR and Beclin 1 complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Regulation of TFEB and V-ATPases by mTORC1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Functional genomics reveal that the serine synthesis pathway is essential in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Safety and pharmacokinetics of escalated doses of weekly intravenous infusion of CCI-779, a novel mTOR inhibitor, in patients with cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

4E-binding protein 1, a cell signaling hallmark in breast cancer that correlates with pathologic grade and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Reciprocal changes in gene expression profiles of cocultured breast epithelial cells and primary fibroblasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Response to mTOR inhibition: activity of eIF4E predicts sensitivity in cell lines and acquired changes in eIF4E regulation in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Tumor slices as a model to evaluate doxorubicin in vitro treatment and expression of trios of genes PRSS11, MTSS1, CLPTM1 and PRSS11, MTSS1, SMYD2 in canine mammary gland cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Preclinical evaluation of transcriptional targeting strategies for carcinoma of the breast in a tissue slice model system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Dynamic modularity in protein interaction networks predicts breast cancer outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Akt is frequently activated in HER2/neu-positive breast cancers and associated with poor prognosis among hormone-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Gene expression profile in response to doxorubicin-rapamycin combined treatment of HER-2-overexpressing human mammary epithelial cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Preclinical model of organotypic culture for pharmacodynamic profiling of human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Activated Akt expression in breast cancer: correlation with p53, Hdm2 and patient outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

mTOR: from growth signal integration to cancer, diabetes and ageing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00441-013-1608-8

10.1007/S00441-013-1608-8

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

1003565628

0 references

1 reference